nach oben

Erschienen in:

01.10.2022 | News item

Sanofi UK recalls batches of teicoplanin due to bacterial endotoxins

Erschienen in: Reactions Weekly | Ausgabe 1/2022

Einloggen, um Zugang zu erhalten

Excerpt

Sanofi is recalling two batches of teicoplanin (Targocid 200mg powder for solution for injection/infusion or oral solution) in the UK due to the presence of bacterial endotoxins, reports the Medicines and Healthcare products Regulatory Authority (MHRA). …

National Patient Safety Alert: Class 1 Medicines Recall Notification: Recall of Targocid 200mg powder for solution for injection/infusion or oral solution, Aventis Pharma Limited t/a Sanofi, due to the presence of bacterial endotoxins, NatPSA/2022/008/MHRA Internet Document : 26 Oct 2022. Available from: URL: https://bit.ly/3TXv4jj

Titel: Sanofi UK recalls batches of teicoplanin due to bacterial endotoxins
Publikationsdatum: 01.10.2022
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2022
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-022-26269-7

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2022

Multiple drugs

Daptomycin/levetiracetam/valproic acid

Alectinib/ceritinib/etoposide

Antineoplastics

Aripiprazole

Isoniazid/linezolid